FERRARO, GIARITA
 Distribuzione geografica
Continente #
AS - Asia 4.043
NA - Nord America 3.842
EU - Europa 2.469
SA - Sud America 498
Continente sconosciuto - Info sul continente non disponibili 218
AF - Africa 87
OC - Oceania 17
Totale 11.174
Nazione #
US - Stati Uniti d'America 3.646
SG - Singapore 1.772
RU - Federazione Russa 1.057
IT - Italia 819
CN - Cina 757
VN - Vietnam 699
BR - Brasile 389
HK - Hong Kong 288
FR - Francia 136
DE - Germania 120
BD - Bangladesh 114
CA - Canada 93
IN - India 84
JP - Giappone 80
GB - Regno Unito 71
MX - Messico 55
KR - Corea 51
AR - Argentina 47
FI - Finlandia 42
IE - Irlanda 37
PH - Filippine 29
AT - Austria 26
NL - Olanda 26
TW - Taiwan 23
ES - Italia 21
ZA - Sudafrica 21
CI - Costa d'Avorio 20
SE - Svezia 20
IQ - Iraq 19
PL - Polonia 19
TH - Thailandia 19
CO - Colombia 16
ID - Indonesia 15
EC - Ecuador 13
LT - Lituania 12
UA - Ucraina 12
PK - Pakistan 11
TR - Turchia 11
VE - Venezuela 11
NZ - Nuova Zelanda 9
AU - Australia 8
CR - Costa Rica 8
IL - Israele 8
DZ - Algeria 7
EG - Egitto 7
MA - Marocco 7
PE - Perù 7
JM - Giamaica 6
PY - Paraguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
CH - Svizzera 5
GT - Guatemala 5
IR - Iran 5
KZ - Kazakistan 5
LB - Libano 5
NO - Norvegia 5
NP - Nepal 5
SA - Arabia Saudita 5
BB - Barbados 4
CL - Cile 4
EE - Estonia 4
JO - Giordania 4
NG - Nigeria 4
PT - Portogallo 4
RO - Romania 4
AZ - Azerbaigian 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
HN - Honduras 3
MY - Malesia 3
NI - Nicaragua 3
PR - Porto Rico 3
RS - Serbia 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
HT - Haiti 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MT - Malta 2
OM - Oman 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AD - Andorra 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 10.933
Città #
Singapore 879
San Jose 797
Ashburn 419
Hong Kong 277
Moscow 235
Council Bluffs 207
Beijing 202
Hefei 199
Chandler 194
Ho Chi Minh City 191
Naples 168
Hanoi 152
Santa Clara 127
Napoli 114
Los Angeles 97
Lauterbourg 96
The Dalles 68
Tokyo 68
New York 54
São Paulo 54
Dallas 52
Milan 49
Millbury 49
Boston 45
Buffalo 45
Rome 40
Seoul 40
Des Moines 37
Phoenix 35
Da Nang 34
Princeton 33
Redondo Beach 32
Lawrence 31
Haiphong 29
Nanjing 29
Munich 27
Chicago 24
Atlanta 23
Denver 22
Frankfurt am Main 22
Houston 22
Orem 22
Dong Ket 21
Florence 21
Wilmington 20
Falkenstein 19
Mexico City 19
Seattle 19
Toronto 19
Amsterdam 18
Montreal 18
London 17
Vienna 17
Rio de Janeiro 16
Brooklyn 14
Ottawa 14
Warsaw 14
Biên Hòa 13
Helsinki 13
Chennai 12
Stockholm 12
Hebei 11
Manchester 11
Washington 11
Miami 10
Mumbai 10
Nanchang 10
Thái Nguyên 10
Baghdad 9
Düsseldorf 9
Johannesburg 9
Kochi 9
San Francisco 9
Shenyang 9
Turku 9
Brasília 8
Can Tho 8
Fairfield 8
Guangzhou 8
Miguel Hidalgo 8
Poplar 8
Curitiba 7
Dublin 7
Marigliano 7
New Delhi 7
Padova 7
Salerno 7
Caserta 6
Hải Dương 6
Jiaxing 6
Pune 6
Querétaro 6
Thái Bình 6
Vilnius 6
Wuhan 6
Casablanca 5
Catania 5
Figino 5
Memphis 5
Ninh Bình 5
Totale 5.955
Nome #
Structural insights and aggregation propensity of a super-stable monellin mutant: A new potential building block for protein-based nanostructured materials 249
Label-free quantitative proteomics of the MCF-7 cellular response to a ferritin-metallodrug complex. 214
C-Glycosylation in platinum-based agents: a viable strategy to improve cytotoxicity and selectivity 207
Inside out Porphyridium cruentum: Beyond the Conventional Biorefinery Concept 181
A thermophilic C-phycocyanin with unprecedented biophysical and biochemical properties 177
A highly efficient and selective antitumor agent based on a glucoconjugated carbene platinum(ii) complex 175
Analisi minero-petrografiche, chimiche e microbiologiche condotte sulla scultura denominata Real Infante Carlo Tito di Borbone 169
Five-Coordinate Platinum(II) Compounds Containing Sugar Ligands: Synthesis, Characterization, Cytotoxic Activity, and Interaction with Biological Macromolecules 166
Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity 164
Chloride-free hydrolytic sol–gel synthesis of Nb–P–Si oxides: an approach to solid acid materials 164
Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems 157
Impact of Hydrophobic Chains in Five-Coordinate Glucoconjugate Pt(II) Anticancer Agents 156
A Diruthenium Metallodrug as a Potent Inhibitor of Amyloid-β Aggregation: Synergism of Mechanisms of Action 154
Gold-based drug encapsulation within a ferritin nanocage: X-ray structure and biological evaluation as a potential anticancer agent of the Auoxo3-loaded protein 153
Mapping the protein-binding sites for iridium(III)-based CO-releasing molecules 150
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 149
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct 146
A new and efficient procedure to load bioactive molecules within the human heavy-chain ferritin nanocage 145
Five-Coordinate Platinum(II) Compounds as Potential Anticancer Agents 144
Reaction with Proteins of a Five-Coordinate Platinum(II) Compound 143
Cisplatin-Protein Interactions: Unexpected Drug Binding to N-Terminal Amine and Lysine Side Chains 141
Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes 140
The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c. 138
Preparation, structure, cytotoxicity and mechanism of action of ferritin-Pt(II) terpyridine compound nanocomposites 138
Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands 138
Effect of temperature on the interaction of cisplatin with the model protein hen egg white lysozyme 136
Modulation of amyloidogenic peptide aggregation by photoactivatable co-releasing ruthenium(II) complexes 136
Non‐Covalent and Covalent Binding of New Mixed‐Valence Cage‐like Polyoxidovanadate Clusters to Lysozyme 134
Cisplatin binding to human serum albumin: a structural study 133
Platinated oligomers of bovine pancreatic ribonuclease: Structure and stability. 131
Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells 130
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(i) heterobimetallic derivatives 128
X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage 128
Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage 128
Protein-mediated disproportionation of Au(i): insights from the structures of adducts of Au(iii) compounds bearing N,N-pyridylbenzimidazole derivatives with lysozyme 125
Deciphering the role of neutral diruthenium complexes in protein binding 124
Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme 124
Structural Characterization of a Gold/Serum Albumin Complex 122
Unusual mode of protein binding by a cytotoxic π-arene ruthenium(ii) piano-stool compound containing an O,S-chelating ligand 121
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 120
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 120
The non-swapped monomeric structure of the arginine-binding protein from Thermotoga maritima 117
Cisplatin binding to β-lactoglobulin: A structural study 116
Exchange of Equatorial Ligands in Protein-bound Paddlewheel Ru25+ Complexes: New Insights form X-ray Crystallography and Quantum Chemistry 115
First Crystal Structure for a Gold Carbene-Protein Adduct 114
Halo complexes of gold(I) containing glycoconjugate carbene ligands: synthesis, characterization, cytotoxicity and interaction with proteins and DNA model systems 112
Ruthenium(II)-Arene Complexes with Glycosylated NHC-Carbene Co-Ligands: Synthesis, Hydrolytic Behavior, and Binding to Biological Molecules 111
Bioactive Molecules Delivery through Ferritin Nanoparticles: Sum Up of Current Loading Methods 109
Unusual structural features in the adduct of dirhodium tetraacetate with lysozyme 109
Interaction of Platinum-based Drugs with Proteins: An Overview of Representative Crystallographic Studies 109
Dirhodium tetraacetate binding to a B-DNA double helical dodecamer probed by X-ray crystallography and mass spectrometry 108
Arsenoplatin-ferritin nanocage: Structure and cytotoxicity 108
Protein-metallodrugs interactions: Effects on the overall protein structure and characterization of Au, Ru and Pt binding sites 108
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 102
X-ray structure of C-phycocyanin from Galdieria phlegrea: Determinants of thermostability and comparison with a C-phycocyanin in the entire phycobilisome 102
On the productive function of furnaces in archaeological sites 100
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 99
Evaluation of Auranofin Loading within Ferritin Nanocages 99
Biotic and environmental stress induces nitration and changes in structure and function of the sea urchin major yolk protein toposome 99
Interaction of VIVO-8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 97
Unexpected in crystallo reactivity of the potential drug bis(maltolato)oxidovanadium(iv) with lysozyme 95
First Structural Evidence of Binding Modes of Decavanadate to a Protein: Insights from NMR and X-ray Crystallography 95
Binding Modes of Decavanadate to a Protein: first structural Insights from NMR, Mass Spectrometry and X-ray Crystallography 88
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 88
On the mechanism of action of arsenoplatins: arsenoplatin-1 binding to a B-DNA dodecamer 86
Exploring the interactions between model proteins and Pd(II) or Pt(II) compounds bearing charged N,N-pyridylbenzimidazole bidentate ligands by X-ray crystallography 81
Structural and in Solution Studies on the Interaction of a Vanadium(V) Complex with Lysozyme 80
Cisplatin Binding Sites in Human H-Chain Ferritin 79
Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies 78
Cisplatin Binding to Human Serum Transferrin: A Crystallographic Study 77
Steric hindrance and charge influence on the cytotoxic activity and protein binding properties of diruthenium complexes 77
Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance 75
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 75
Interactions of cisplatin analogues with lysozyme: a comparative analysis 74
Effect of Equatorial Ligand Substitution on the Reactivity with Proteins of Paddlewheel Diruthenium Complexes: Structural Studies 73
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A 73
Ru-Based CO releasing molecules with azole ligands: interaction with proteins and the CO release mechanism disclosed by X-ray crystallography 72
Metal-based carbon monoxide releasing molecules with promising cytotoxic properties 71
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 69
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 68
Principles and methods used to grow and optimize crystals of protein-metallodrug adducts, to determine metal binding sites and to assign metal ligands 67
Protein interactions of dirhodium tetraacetate: a structural study 66
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity 65
Mitochondria Targeting with Luminescent Rhenium(I) Complexes 65
The NAMI A-human ferritin system: A biophysical characterization 64
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells 63
Charge effect in protein metalation reactions by diruthenium complexes 62
Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity 57
Cisplatin/Apo-Transferrin Adduct: X-ray Structure and Binding to the Transferrin Receptor 1 55
Reactions with proteins of three novel anticancer platinum(Ii) complexes bearing N-heterocyclic ligands 55
Speciation and structural transformation of a VV–malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate 54
Binding of [VIVO(8-HQ)(H2O)]+ to the model protein lysozyme: structural and computational studies 50
Non-covalent Interactions with Proteins of Potential Vanadium Drugs: The Case of the Lysozyme/VIVO-8-hydroxyquinoline adduct 49
V-based drug binding to RNase A 46
Formation of Mixed-Valence Cage-Like Polyoxidovanadates at 37°C Upon Reaction of VIVO(acetylacetonato)2 With Lysozyme 42
Binding to proteins of the pharmacologically active bis(maltolato)oxidovanadium(IV) 42
Interaction of VVO2−hydrazonates with lysozyme 41
Binding to Lysozyme of the Pharmacologically Active VIVO−Pyridinone Drug 41
Binding of oxidovanadium(IV) complexes [VIVO(malt)2] and [VIVO(empp)2] to lysozyme 40
X-ray structures of adducts formed upon reaction of lysozyme with a vanadate complex of 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone 39
Totale 10.769
Categoria #
all - tutte 36.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 0 3 9 4 7 23 40 11 88 131
2022/2023465 64 33 18 22 63 53 22 59 69 11 39 12
2023/2024417 20 63 54 33 26 49 11 30 9 22 64 36
2024/20252.436 105 149 46 22 55 110 262 164 207 241 857 218
2025/20265.776 430 391 556 635 964 299 768 327 756 315 179 156
2026/20271.108 153 357 252 346 0 0 0 0 0 0 0 0
Totale 11.174